Kuwait vs Palau: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Kuwait
95.0%
in 2025
Palau
95.0%
in 2025
Kuwait rank
38th
Palau rank
38th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Kuwait
- Palau
How they compare
Kuwait currently reports 95.0% against 95.0% in Palau, a difference of 0.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Kuwait ahead.
Kuwait ranks 38th and Palau ranks 38th of 194 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kuwait | Palau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 99.0% | 12.5% | 86.5% | Kuwait |
| 2010s | 97.0% | 81.2% | 15.8% | Kuwait |
| 2020s | 96.5% | 86.0% | 10.5% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Kuwait or Palau?
- Kuwait, at 95.0% against 95.0% in Palau as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Kuwait and Palau?
- 0.0%, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Palau?
- 18 years are reported by both, from 2008 to 2025.
- How do Kuwait and Palau rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Kuwait ranks 38th and Palau ranks 38th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.